Accessibility Menu
Adheris Health logo

Adheris Health(ASX) MDR

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-96%
5 Year-96%
1 Year-75%
1 Month-6%
N/A
Adheris Health last closing stock price
MetricPriceDate
Last closeAUD 0.022026-08-13
Adheris Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.88%AUD 0.022026-08-06
1 month-5.88%AUD 0.022026-07-14
3 month-20%AUD 0.022026-05-15
Year to date-20%AUD 0.022025-12-31
1 year-75%AUD 0.062025-08-12
3 year-92.89%AUD 0.232023-08-14
5 year-95.56%AUD 0.362021-08-13
Since inception-95.54%AUD 0.362015-12-01

Adheris Health Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$185.10M

Net Income (TTM)

-A$62.53M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Feb 26, 2026

MDR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adheris Health

MedAdvisor Limited is a healthcare technology company focused on improving medication management and adherence through innovative software solutions. Operating across Australia, the United States, the United Kingdom, and Asia, the company aims to enhance health outcomes by connecting healthcare professionals with patients.

Products and Services
  • MedAdvisor platform for medication management and adherence
  • THRiV, an intelligent digital solution for adherence
  • GuildCare, a cloud-hosted platform for healthcare solutions
Growth Outlook
  • Recent quarterly revenue reached AUD 58.88 million, indicating strong demand
  • Positive net income of AUD 1.4 million in Q2 2024 shows operational efficiency
  • Significant cash flow from operations of AUD 11.04 million in Q2 2024
Financial Highlights
  • Trailing twelve-month revenue of AUD 75.55 million reflects robust growth
  • Operating income margin improved to 12.72% in Q2 2024
  • Cash and cash equivalents stood at AUD 22.53 million as of December 2023
MedAdvisor Limited is positioned in the healthcare information services industry, leveraging technology to address medication adherence challenges. The company's flagship platform, MedAdvisor, is designed to facilitate better communication between healthcare providers and patients, ultimately leading to improved health outcomes. The introduction of THRiV and GuildCare further diversifies the product offerings, catering to various healthcare needs. The growth outlook appears promising, with recent financial performance indicating a positive trajectory. The substantial revenue growth and net income in the latest quarter suggest that the company is effectively capitalizing on market opportunities. Additionally, the strong cash flow from operations highlights the company's ability to generate funds for future investments and operational needs. Financially, MedAdvisor has demonstrated resilience, with a trailing twelve-month revenue of AUD 75.55 million. The improvement in operating income margin to 12.72% in Q2 2024 reflects enhanced operational efficiency. Furthermore, a solid cash position of AUD 22.53 million as of December 2023 provides a buffer for ongoing operations and potential expansion initiatives. Overall, MedAdvisor Limited presents a compelling case for potential investors interested in the healthcare technology sector, particularly in solutions that enhance medication management and patient adherence.
AI Generated • Jul 19, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Richard Ratliff, MBA

Website

www.medadvisor.com.au

Headquarters

Camberwell, VIC 3124, AU

MDR Financials

Key Financial Metrics (TTM)

Gross Margin

-38.88%

Operating Margin

-81.59%

Net Income Margin

-196.24%

Return on Equity

-1566.68%

Return on Capital

-42.67%

Return on Assets

-206.20%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$27.36M

Operating Income

-A$1.79M

EBITDA

-A$53.03M

Operating Cash Flow

-A$9.18M

Capital Expenditure

-A$856.72K

Free Cash Flow

-A$10.03M

Cash & ST Invst.

A$10.30M

Total Debt

A$17.40M

Adheris Health Performance Analysis

Adheris Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 67,750,061N/A
20232023-06-30AUD 97,963,27244.6%
20242024-06-30AUD 98,403,4040.4%
20252025-06-30AUD 62,994,989-36.0%
Adheris Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-12-31123.0%
Q42024-06-30-38.4%
Q22024-12-3122.7%
Q42025-06-30-89.7%
Adheris Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.05N/A
20232023-06-30AUD -0.02-54.7%
20242024-06-30AUD 0.00N/A
20252025-06-30AUD -0.11N/A
Adheris Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-12-31138.7%
Q42024-06-30-188.7%
Q22024-12-31122.5%
Q42025-06-30-4382.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$5.89M

-82.6%

Gross Profit

-A$11.32M

-332.0%

Gross Margin

-1.92%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-A$64.72M

-307.0%

EBITDA

-A$62.07M

-434.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$10.30M

-27.4%

Total Debt

A$17.40M

+32.9%

Accounts Receivable

A$7.82M

-33.3%

Inventory

A$0.00

N/A

Long Term Debt

A$17.31M

+40.6%

Short Term Debt

A$81.71K

-89.5%

Return on Assets

-2.06%

N/A

Return on Invested Capital

-2.53%

N/A

Free Cash Flow

-A$8.13M

+52.8%

Operating Cash Flow

-A$8.24M

+52.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IME.AXImExHS Limited
A$0.31-3.13%
PAB.AXPatrys Limited
A$0.03-3.13%
NC6.AXNanollose Limited
A$0.08+4.00%
AGH.AXAlthea Group Holdings Limited
A$0.02-4.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About MDR

What is the current price of Adheris Health?

Adheris Health is trading at N/A per share.

What is the 52-week range for Adheris Health?

Over the past 52 weeks, Adheris Health has traded between N/A and N/A.

How much debt does Adheris Health have?

As of the most recent reporting period, Adheris Health reported total debt of A$17.40M.

How much cash does Adheris Health have on hand?

Adheris Health reported A$10.30M in cash and cash equivalents in its most recent financial results.

What is Adheris Health’s dividend yield?

Adheris Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services